Cory Gilvary

Chief Data Scientist & Co Founder of @OneThreeBiotech. Lover of all things #AI, #DrugDevelopment and #BigData. Views are my own! (she/her)

[Cory Gilvary @Coryandar]

@andruyeung Would love to join!

[Simon Willison @simonw]

OK, I'm calling it: Large language models are having their Stable Diffusion moment right now
https://t.co/5GPHHHMunX

[Amanda Goetz @AmandaMGoetz]

If you think #IWD2023 is silly bc “it’s 2023 and women have it good”

Let’s review the numbers

⏺️ Women earn .82 to the male $1
⏺️ 42% of US women will be sexually assaulted
⏺️ < 2% of VC dollars fund women
⏺️ 75% of women who pay for childcare say it’s more than they make

[Cory Gilvary @Coryandar]

Had a great time @CapitalFactory giving OneThree's pitch to @sm_atx. Perfect way to kick-off #SXSW !

[Austin Startup Meetup @sm_atx]

@Coryandar presented @OneThreeBiotech, a venture backed, clinically validated, AI-driven drug discovery startup with a focus on identifying first-in-class therapeutics. 🌟 Keep an eye on this company as it scales and continues to transform the field of drug discovery! 🙌

[Cory Gilvary @Coryandar]

@NFTequilaa 👋hello! Female co-founder here! Would love to join! I’ve been eager to network with other female founders and investors!

[Cory Gilvary @Coryandar]

@andruyeung 👋 I’m a co-founder of @OneThreeBiotech, an AI driven drug discovery biotech! Sounds like a great party, would love to join!

[Cory Gilvary @Coryandar]

@CamirRicketts This also goes for the programmers...so many times after I "reboot" aka take a walk/nap/break, things are so much easier!

[Cory Gilvary @Coryandar]

@JoshuaBaer Hello! I’m Chief Data Scientist/co-founder of @OneThreeBiotech and would love to meet biotech/tech investors, other Austin based founders and you (I’ve been curious about Capital factory for while) during SXSW!

[Nature Biotechnology @NatureBiotech]

Deconvolution of clinical variance in CAR-T cell pharmacology and response https://t.co/fd6QHoRDpk

[Cory Gilvary @Coryandar]

It’s been amazing working with @PoolbegPharma on finding new treatments for RSV.

[Poolbeg Pharma @PoolbegPharma]

Artificial Intelligence 🤖 is a #hottopic 🔥

👂Tune into a discussion between #POLB & @OneThreeBiotech on #AI trends & our collaboration, which identified #RSV drug candidates using AI - a world first!

https://t.co/jEo1g9SkSl

$POLBF

[Angelos Georgakis @angelosgeo]

George Church on the founder-led biotech movement:

"The student/postdoc is more motivated, more knowledgeable, and more capable of getting a technology out into the public, where it can do some good... 1/4

[Cory Gilvary @Coryandar]

Funny example of a common issue - subject matter experts should be part of the building of algorithms NOT just consulted after the fact! This is why cross-discipline training is so important if ML is going to make the widespread impact that's been promised.

[Daniela Witten @daniela_witten]

A case study on why your ML team should work with subject matter experts …. Or, in this particular case, should INCLUDE subject matter experts

[Nashlie Sephus, PhD @phenomenashlie]

For any developers or students interested in implementing Responsible AI in your algorithms, check out Amazon MLU's (Machine Learning University) free course! From definitions to Jupyter notebook coding examples, we've got you covered.
https://t.co/EZkqRwTSwM

[Henri Pierre-Jacques @hpierrejacques]

🧵 We just had a webinar with our LPs, here’s what we told them we are seeing in the current market

[Simona Cristea @simocristea]

The incredible field of protein structure prediction has come a long way since AlphaFold's breakthrough in 2021.

Now in 2023, @naturemethods has written an editorial highlighting how the field has evolved.

Here's a compilation of these #DeepLearning protein resources👇

[bioRxiv @biorxivpreprint]

Exploring the onset and progression of prostate cancer through a multicellular agent-based model https://t.co/evFQR0bRCE #bioRxiv

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Application of Bayesian approaches in drug development: starting a virtuous cycle https://t.co/GxPFRA3J6u

A new Perspective that highlights the value of Bayesian methods in drug development, discusses barriers to their application and recommends approaches to address them

[Danny Richman @DannyRichman]

I mentor a young lad with poor literacy skills who is starting a landscaping business. He struggles to communicate with clients in a professional manner.

I created a GPT3-powered Gmail account to which he sends a message. It responds with the text to send to the client.

[Dr Dale Whelehan @DrDaleford]

🙌 THE 4 DAY WORK WEEK HAS HIT IRELAND WITH ASTONISHING RESULTS. 🙌

The Irish Findings are as follows:
• 100% of the companies involved are continuing with the 4-Day work week ➡
• 85% of companies which reported data on revenue reported growth in revenue 📈 (1/X)